About us
The Swiss GO Trial Group is a non-profit organisation.
The Swiss GO Trial Group has set itself the task of promoting academic research in the field of gynaecological oncology, in particular ‘out-of-the-box’ approaches. New therapeutic and diagnostic approaches should take the latest advances in precision medicine and the molecular causes of cancer into account. The aim is to increase the visibility of clinical research in Switzerland and to raise the profile of Swiss research internationally. To this end, Swiss-GO acts as the main sponsor and supporter of such studies. Its Membership in the European network (ENGOT) and the International Trial Group (GCIG) has also proved beneficial. The patients' perspective is also very important; 4 patient advocates ensure that the trials are planned and conducted in accordance with the needs of gynaecological oncology patients.
As of 2025, the Swiss-GO is a research structure of national importance, funded by the State Secretariat of Education; Research and Innovation (SERI).
All studies on gynecological cancer research should find a place at Swiss-GO.
Would you like to participate in a study or have an idea for a study, let us accompany you!
Swiss GO Trial Group Team
Picture, from left to right:
Pamela Mclaughlin, PhD (Research Associate/Clinical Study Manager), Sangeetha Martin Maretvadakethope, M.B.B.S., M.Sc., PD Dr. André Fedier, PhD, Ovarian Cancer Research (Managing Director Swiss-GO), Maren Vogel, PhD (Research Associate/Clinical Study Manager), Prof. Dr. med. Viola Heinzelmann (President Swiss-GO), Michael von Rotz (CFO), Arppana Rajan MSc. (Clinical Study Manager), Anett Jacob, B.Sc. (Clinical Study Manager)
Board Members
Picture, from left to right:
PD Dr. André Fedier, (CEO Swiss-GO), PD Dr. med. Seraina Schmid, Dr. med. Sana Intidhar Labidi-Galy, Prof. Dr. med. Viola Heinzelmann, lic.iur. Jacqueline Burckhardt Bertossa and PD Dr. med. Marcus Vetter.
Missing Board Members, not on the picture: Prof. Dr. med. Stefan Aebi, Prof. Dr. med. Christian Kurzeder, Dr. med. Fernanda Herrera and Dr. med. Maria Del Grande.
Patient Advocacy Group
Picture, from left to right:
Prof. Dr. med Viola Heinzelmann-Schwarz, Ms. Yolanda Hofer, Dr. Katrin Stamm and Ms. Mubera Krijezi.
As patient engagement in healthcare improves health outcomes, the Swiss GO Trial Group has founded a patient advocacy group.
We are very grateful that Ms.Yolanda Hofer, Ms. Mubera Krijezi and Dr. Katrin Stamm are willing to take upon them this task of becoming engaged in the trials that the Swiss GO Trial Group conducts, to improve trial outcomes.
Do You Have Questions? We are there for you!
Swiss GO Trial Group Organization
Responsible:
Pamela McLaughlin PhD
Maren Vogel PhD
Organization:
Swiss GO Trial Group, c/o USB, Basel
Address:
Swiss GO Trial Group
Gynecological Oncology
Hospital for Women
University Hospital Basel
Spitalstrasse 21
CH-4031 Basel
Switzerland
Phone: +41 61 265 75 00
Fax: +41 61 265 93 22
E-mail:
Bank accounts:
Donate:
IBAN CH43 0844 0258 2736 6200 2
Membership:
IBAN CH70 0844 0258 2736 6200 1
